AstraZeneca Plans To Drug The Undruggable With Scorpion Partnership

Pays $75m Upfront

 
• By Ayisha Sharma

The UK major will work with the US biotech to develop up to three precision medicines targeting cancer proteins previously thought undruggable via conventional methods.    

Microscopic view of cancer cells. Cancer occurs when a cell's gene mutations make the cell unable to correct DNA damage.
The Partners Aim To Disrupt The Activity Of Highly-Validated Cancer Targets • Source: Alamy

More from Deals

More from Business